Advancing the Use of Cancer Vaccines in Glioblastoma to Reprogram the Patient’s Immune System
2:00 pm - Thursday 19th February 2026
- Discussing the importance of tumor antigen selection and balanced immunity in vaccine design
- Addressing the tumor microenvironment to enhance cancer vaccines
